SCHEMBL16783142

SCHEMBL16783142

CCCCNC(=O)CNc1ccccc1N1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.63
ALDH1A1 P00352 4/20 0.63
POLB P06746 4/20 0.57
LMNA P02545 4/20 0.57
SMN1; SMN2 Q16637 2/20 0.53
GAA P10253 2/20 0.49
KMT2A Q03164 6/20 0.47
NPSR1 Q6W5P4 5/20 0.47
TSHR P16473 2/20 0.47
PLA2G1B P04054 2/20 0.47
ATG4B Q9Y4P1 2/20 0.47
KCNQ2 O43526 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
PKM P14618 1/20 0.47
MEN1 O00255 4/20 0.47
ATM Q13315 2/20 0.46
USP2 O75604 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16804882 0.81 ALDH1A1 (0.64) MAPTALDH1A1POLBLMNASMN1; SMN2
SCHEMBL5545979 0.77 ALDH1A1 (0.65) MAPTALDH1A1POLBLMNASMN1; SMN2
Toluene SCHEMBL27898610 0.77 ALDH1A1 (0.49) MAPTALDH1A1POLBLMNASMN1; SMN2
SCHEMBL7896507 0.76 MAPT (0.64) MAPTALDH1A1POLBLMNASMN1; SMN2
Hydrochloric Acid SCHEMBL7888531 0.76 MAPT (0.57) MAPTALDH1A1POLBLMNASMN1; SMN2
Hydrochloric Acid SCHEMBL7895987 0.76 MAPT (0.63) MAPTALDH1A1POLBLMNASMN1; SMN2
Hydrochloric Acid SCHEMBL7896677 0.75 MAPT (0.62) MAPTALDH1A1POLBLMNASMN1; SMN2
SCHEMBL10199973 0.74 MAPT (0.56) MAPTALDH1A1POLBLMNASMN1; SMN2
Isophthalic Acid SCHEMBL27822644 0.74 KMT2A (0.50) MAPTALDH1A1POLBLMNASMN1; SMN2
Hydrochloric Acid SCHEMBL7898969 0.72 MAPT (0.58) MAPTALDH1A1POLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150164910-A1 ANTIVIRAL COMPOUNDS AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164910-A1 ANTIVIRAL COMPOUNDS AND METHODS OF USE EIF2AK2, RNASE1, HAVCR2 MAPT 4474/4885ALDH1A1 4417/4885POLB 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.